Shopping Cart
- Remove All
- Your shopping cart is currently empty
Setrusumab (BPS 804) is a fully humanized monoclonal antibody targeting sclerostin, effectively enhancing bone strength, used in research on Osteogenesis Imperfecta (OI) and cancer [1].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | Inquiry | Backorder | |
5 mg | Inquiry | Backorder |
Description | Setrusumab (BPS 804) is a fully humanized monoclonal antibody targeting sclerostin, effectively enhancing bone strength, used in research on Osteogenesis Imperfecta (OI) and cancer [1]. |
In vivo | Setrusumab, administered at a dosage of 100 mg/kg via intravenous injection once weekly for a duration of four weeks, inhibited bone metastasis and muscle weakness induced by breast cancer in mice [1]. |
Alias | BPS 804 |
Cas No. | 1847394-95-9 |
Storage | store at -20°C | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.